Recombinant Staphylococcus aureus UPF0382 membrane protein SAV0583 (SAV0583) is a protein derived from the bacterium Staphylococcus aureus . Specifically, it is a full-length recombinant protein, which means it is produced using recombinant DNA technology, where the gene encoding the protein is inserted into a host organism (such as E. coli) to produce the protein in large quantities . The protein is tagged with a histidine tag (His-tag) at the N-terminal, which facilitates its purification using affinity chromatography .
Proteins can be structural, regulatory, contractile, or protective . They participate in transport, storage, and the formation of membranes, and they can also act as toxins or enzymes .
2.1 Primary Structure
The primary structure of a protein refers to the unique sequence of amino acids in a polypeptide chain . This sequence is crucial because it dictates the three-dimensional conformation that the folded protein will adopt, which in turn determines its function . The sequence of amino acids gives the protein its identity and characteristics .
2.2 Secondary Structure
The secondary structure of a protein arises from the local folding of the polypeptide chain in certain regions . The most common secondary structures are the α-helix and β-pleated sheet . These structures are maintained by hydrogen bonds . In an α-helix, hydrogen bonds form between the oxygen atom in the carbonyl group of one amino acid and another amino acid four residues farther along the chain . The R groups (side chains) of the amino acids protrude outward from the α-helix . In a β-pleated sheet, hydrogen bonding occurs between atoms on the backbone of the polypeptide chain, forming the "pleats" . The R groups are attached to the carbons and extend above and below the folds of the pleat .
| Structure | Description | Stabilizing Force |
|---|---|---|
| α-Helix | Coiled structure with hydrogen bonds between amino acids four residues apart | Hydrogen bonds |
| β-Pleated Sheet | Alignment of polypeptide segments with hydrogen bonds between amino and carboxyl groups in the peptide backbone | Hydrogen bonds |
2.3 Tertiary Structure
The tertiary structure is the unique three-dimensional structure of the polypeptide . It is primarily due to chemical interactions among the R groups of the amino acids . These interactions can include hydrogen bonds, ionic bonds, hydrophobic interactions, and disulfide bridges . Hydrophobic R groups tend to lie in the protein's interior, while hydrophilic R groups are on the exterior .
SAV0583 is implicated in the pathogenesis of Staphylococcus aureus, particularly in biofilm formation . Biofilms are three-dimensional structures composed of bacteria and host material that colonize implanted medical devices, making them a critical factor in implant-associated infections .
3.1 Biofilm Formation
Biofilm formation involves several steps:
Attachment: Bacteria attach to the surface of a medical device .
Proliferation: Bacteria proliferate and accumulate into multilayered cell clusters .
SAV0583 contributes to cell aggregation and biofilm accumulation . Specifically, the N-terminal domain of SAV0583 is responsible for conferring cell aggregation and enhanced biofilm formation .
3.2 Cell Aggregation
SAV0583 promotes intercellular adhesion, leading to the formation of large cell aggregates . This aggregation is crucial for establishing a robust biofilm structure .
3.3 Binding Properties
SAV0583 does not mediate binding to fibrinogen, thrombospondin-1, von Willebrand factor, or platelets . This suggests that its role in pathogenesis is more related to structural aspects of biofilm formation rather than direct interaction with host extracellular matrix proteins .
KEGG: sav:SAV0583
STRING: 158878.SAV0583
SAV0583 is a membrane protein belonging to the UPF0382 protein family in Staphylococcus aureus. It shares significant homology with similar proteins like MW0538 (from S. aureus MW2 strain), which consists of 122 amino acids forming a membrane-associated structure. The protein is characterized by its hydrophobic regions that facilitate membrane anchoring and potential scaffold functions within bacterial membrane microdomains . SAV0583 represents one of several strain-specific variants of UPF0382 family proteins in S. aureus, with approximately 84% sequence identity to homologous proteins in related bacterial species such as B. subtilis FloA .
Based on comparative analysis with similar UPF0382 family proteins, SAV0583 likely exhibits the following structural characteristics:
A full protein sequence of approximately 122 amino acids
Hydrophobic transmembrane domains that anchor the protein to the bacterial membrane
Structural motifs consistent with scaffold protein functionality
Potential oligomerization domains that facilitate protein-protein interactions
Association with detergent-resistant membrane (DRM) fractions of S. aureus
The amino acid sequence would be similar to that of related proteins like MW0538, which has the sequence: MKLFIILGALNAMMAVGTGAFGAHGLQGKISDHYLSVWEKATTYQMYHGLALLIIGVISGTTSINVNWAGWLIFAGIIFFSGSLYILVLTQIKVLGAITPIGGVLFIIGWIMLIIATFKFAG .
The membrane localization of SAV0583 is essential for its biological function as it allows the protein to serve as a scaffold within functional membrane microdomains (FMMs). This positioning enables SAV0583 to facilitate the spatial organization and oligomerization of various protein complexes involved in critical cellular processes . Similar to flotillin proteins, SAV0583 likely promotes the concentration of specific proteins within distinct membrane regions, enhancing their interaction efficiency and stabilizing multi-protein complexes. This compartmentalization within the membrane is particularly important for processes requiring coordinated protein assembly, such as RNA degradation machinery and virulence factor regulation .
For optimal expression of recombinant SAV0583, E. coli-based expression systems have proven effective for similar membrane proteins. The recommended methodology includes:
Cloning the SAV0583 gene into an expression vector with an N-terminal His-tag for purification
Transforming the construct into E. coli expression strains optimized for membrane protein production (e.g., BL21(DE3), C41(DE3), or C43(DE3))
Inducing protein expression under controlled conditions (temperature, inducer concentration)
Expression levels should be monitored through SDS-PAGE and Western blot analysis using antibodies against the His-tag or the protein itself. Modifications to growth media, induction temperature (typically lowered to 16-25°C), and induction duration may be necessary to optimize the yield of properly folded protein .
A multi-step purification protocol is recommended for obtaining high-purity SAV0583:
Cell lysis using appropriate detergents that maintain membrane protein integrity
Membrane fraction isolation through differential centrifugation
Solubilization of membrane proteins using mild detergents (e.g., DDM, CHAPS)
Immobilized metal affinity chromatography (IMAC) using the N-terminal His-tag
Size exclusion chromatography to remove aggregates and further purify the protein
Optional ion exchange chromatography for removal of remaining contaminants
This approach typically yields protein with greater than 90% purity as determined by SDS-PAGE . For experimental applications requiring exceptionally high purity, additional chromatography steps may be implemented.
Based on protocols for similar membrane proteins:
Lyophilization in a Tris/PBS-based buffer containing 6% trehalose at pH 8.0 is recommended for long-term storage
Store lyophilized protein at -20°C/-80°C
For reconstituted protein, add 5-50% glycerol (final concentration) and aliquot in small volumes
Store working aliquots at 4°C for up to one week
Avoid repeated freeze-thaw cycles as they significantly reduce protein activity
For reconstitution, centrifuge the vial briefly before opening and dissolve in deionized sterile water to a concentration of 0.1-1.0 mg/mL . The addition of glycerol (optimally 50%) helps prevent protein denaturation during freezing.
Based on studies of homologous proteins, SAV0583 likely functions as a scaffold protein within functional membrane microdomains (FMMs) of S. aureus. Its primary roles may include:
Facilitating the oligomerization of membrane protein complexes
Promoting the spatial organization of virulence-associated protein assemblies
Stabilizing protein-protein interactions within the membrane environment
Contributing to the compartmentalization of cell signaling and metabolic processes
Potentially interacting with RNA degradation machinery (degradosome)
Similar to FloA, SAV0583 may physically interact with RNase components such as Rny, influencing RNA processing and consequently affecting virulence factor expression .
While direct evidence for SAV0583 is limited in the provided search results, studies on homologous proteins suggest:
Deletion of similar scaffold proteins results in altered virulence factor expression
The protein likely stabilizes degradosome components that regulate sRNA transcripts
These sRNA transcripts (such as rsaA and sau63) negatively regulate toxin expression
Disruption of this regulation pathway affects the virulence potential of S. aureus
Small molecules targeting similar proteins reduce S. aureus virulence in both in vitro and in vivo infection models
Research with mutant strains lacking these scaffold proteins has demonstrated reduced virulence in murine and invertebrate infection models, suggesting potential therapeutic applications targeting these membrane proteins .
Based on studies of similar proteins, SAV0583 likely:
Physically interacts with RNase Rny and helps concentrate this enzyme within specific membrane regions
Stabilizes the degradosome complex through scaffold activity
Influences the processing of specific RNA targets, including regulatory sRNAs
Affects the half-life and concentration of sRNA transcripts (e.g., rsaA and sau63)
Indirectly modulates virulence factor expression through these RNA regulatory mechanisms
Cell fractionation experiments with similar proteins have shown that RNase components preferentially concentrate in detergent-resistant membrane fractions where scaffold proteins like SAV0583 are located. Deletion of these scaffold proteins results in altered RNase distribution and function .
When designing experiments to investigate SAV0583 function, the following controls are essential:
Empty vector controls for expression studies
Complementation experiments using wild-type SAV0583 to confirm phenotypes of deletion mutants
Non-functional SAV0583 mutants (e.g., site-directed mutagenesis of key residues)
Appropriate strain backgrounds (clinical isolates vs. laboratory strains)
Time-series measurements to capture dynamic processes
Multiple measurement techniques to confirm observations (e.g., combining microscopy, biochemical assays, and genetic approaches)
For quasi-experimental designs where complete control is not possible, time-series experiments and multiple measurement methods become particularly important to establish causality .
To effectively investigate the membrane localization of SAV0583:
Generate chromosomally integrated tagged constructs (e.g., SAV0583-FLAG) expressed under native promoter control
Perform cell fractionation followed by immunodetection to determine subcellular localization
Use detergent-resistance membrane (DRM) isolation to assess microdomain association
Compare distribution in wild-type vs. mutant backgrounds lacking other scaffold proteins
Employ fluorescence microscopy with tagged proteins to visualize localization patterns
Utilize co-immunoprecipitation to identify interacting partners within the membrane
It is critical to verify that any protein tags do not interfere with membrane localization or protein function through complementation studies with untagged proteins .
A comprehensive experimental design for investigating SAV0583's role in virulence should include:
Generation of clean deletion mutants (ΔSAV0583) and complemented strains
In vitro virulence factor production assays (toxins, enzymes)
Transcriptomic and proteomic analysis of wild-type vs. mutant strains
RNA stability and degradation assays focused on known virulence-associated transcripts
Multiple in vivo infection models with varying complexity:
Invertebrate models (e.g., Galleria mellonella)
Murine infection models (systemic and localized infections)
Time-series tracking of infection progression in each model
For robust causal inference, a multiple time-series design with appropriate controls is recommended, as it addresses many potential threats to validity in biological systems .
Given the potential role of SAV0583 in virulence regulation, several approaches for antimicrobial development could be explored:
High-throughput screening for small molecules that inhibit SAV0583 oligomerization
Structure-based drug design targeting key functional domains of SAV0583
Peptide inhibitors designed to disrupt SAV0583 interactions with partner proteins
Development of compounds that alter membrane microdomain organization
Combination therapies targeting SAV0583 alongside conventional antibiotics
Small molecules identified through these approaches could effectively reduce S. aureus virulence without exerting direct bactericidal effects, potentially reducing selective pressure for resistance development . This anti-virulence approach is particularly promising for addressing infections caused by multidrug-resistant S. aureus strains, including MRSA, which have approximately 20% mortality rates in clinical settings .
Advanced methodologies for mapping SAV0583's interaction network include:
Bacterial two-hybrid systems adapted for membrane proteins
Pull-down assays using tagged SAV0583 followed by mass spectrometry
Proximity labeling approaches (e.g., BioID, APEX) to identify neighboring proteins
Förster resonance energy transfer (FRET) to study interactions in living cells
Cross-linking mass spectrometry to capture transient interactions
Quantitative proteomics comparing wild-type and ΔSAV0583 membrane compositions
These techniques should be used in combination to build a comprehensive interaction map, as each method has specific strengths and limitations for detecting different types of protein-protein interactions, particularly for membrane-associated proteins .
Investigation of post-translational modifications (PTMs) of SAV0583 requires:
Mass spectrometry-based identification of PTMs (phosphorylation, acetylation, etc.)
Site-directed mutagenesis of modified residues to assess functional importance
Identification of enzymes responsible for adding or removing modifications
Temporal analysis of modification patterns under various growth conditions
Correlation of modification states with protein activity and localization
Understanding how PTMs regulate SAV0583 could reveal additional mechanisms for fine-tuning scaffold protein function and potentially identify new targets for therapeutic intervention. Changes in modification patterns during infection could be particularly informative regarding the protein's role in pathogenesis.